T. Rowe Price Associates’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
2021
Q4
$20K Hold
2021
Q3
$27K Sell
2021
Q2
$141K Buy
2021
Q1
$222K Buy
2020
Q4
Sell
2020
Q3
$17K Buy
2020
Q1
Sell
2019
Q4
$2.4M Sell
2019
Q3
$2.43M Sell
2019
Q2
$3.58M Sell
2019
Q1
$4.71M Buy
2018
Q4
$2.47M Sell
2018
Q3
$5.9M Buy